CTOs on the Move

Mary Breckinridge Hospital

www.frontiernursing.org

 
Mary Breckinridge Hospital is a Hyden, KY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

University of Virginia Health System

Based in Charlottesville, Va., UVA Health embodies the leadership and inventiveness personified by its founder, Thomas Jefferson. In 1825, Jefferson established the nation`s 10th medical school, which has since grown into a nationally renowned academic medical center. UVA Health includes a 612-bed hospital, level I trauma center, children`s hospital and primary and specialty clinics throughout Central Virginia. Ranked among the best hospitals by U.S. News & World Report, UVA has doctors, nurses and other healthcare professionals recognized as leaders in their fields and who make every effort to push the envelope of medicine.

UPMC Health Plan

As the second-largest health insurer in western Pa., we serve nearly half a million members and offer a full range of commercial group health insurance and government programs, including Medicare, Medicaid, CHIP, and SNP. Our local provider network totals over 100 hospitals and 11,500 physicians.

D W McMillan Memorial Hospital

D.W. McMillan Memorial Hospital is committed to providing quality healthcare services while treating everyone with respect and compassion. PATIENTS ARE THE FOCUS OF EVERYTHING WE DO. We strive for excellence by working as a team to accomplish cost

Little Company of Mary Hospital and Health Care Centers

Little Company of Mary Hospital and Health Care Centers is a Evergreen Park, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Signal Genetics

Signal Genetics is a commercial stage, molecular diagnostic company focused on providing innovative diagnostic services that help physicians make better-informed decisions concerning the care of their patients suffering from cancer. The company was founded in April 2010 after becoming the exclusive licensee to the world-renowned research on multiple myeloma (MM) performed at the University of Arkansas for Medical Sciences (UAMS). Signal Genetics’ flagship product - MyPRS (Myeloma Prognostic Risk Signature) is based upon more than two decades of clinical research on nearly 10,000 MM patients who received their care at UAMS. Signal Genetics offer the MyPRS test out of its state-of-the-art, CLIA certified reference laboratory located in Little Rock, AR. The company is dedicated to making its extensively validated diagnostic services available to all patients who need them. The mission of Signal Genetics is to develop, validate and deliver innovative diagnostic services that enable better patient-care decisions.